RA Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,416,147
| Closed | -$62.6M | – | 65 |
|
|
2023
Q3 | $62.6M | Hold |
6,416,147
| – | – | 1.23% | 23 |
|
|
2023
Q2 | $76M | Buy |
6,416,147
+416,666
| +7% | +$4.93M | 1.43% | 19 |
|
|
2023
Q1 | $64.7M | Hold |
5,999,481
| – | – | 1.47% | 23 |
|
|
2022
Q4 | $69.4M | Buy |
5,999,481
+1,986,028
| +49% | +$23M | 1.41% | 23 |
|
|
2022
Q3 | $59.9M | Buy |
+4,013,453
| New | +$59.9M | 1.28% | 27 |
|
|
2022
Q1 | – | Sell |
-1,025,641
| Closed | -$8.8M | – | 99 |
|
|
2021
Q4 | $8.8M | Hold |
1,025,641
| – | – | 0.16% | 86 |
|
|
2021
Q3 | $8.63M | Hold |
1,025,641
| – | – | 0.12% | 83 |
|
|
2021
Q2 | $8.32M | Hold |
1,025,641
| – | – | 0.13% | 79 |
|
|
2021
Q1 | $9.01M | Hold |
1,025,641
| – | – | 0.14% | 73 |
|
|
2020
Q4 | $11.5M | Buy |
+1,025,641
| New | +$11.5M | 0.16% | 67 |
|